Lipum (publ) recruited Dr. Fredrik Seijsing to strengthen the preclinical development of SOL-116. Dr. Seijsing has a PhD in Molecular Bioscience from Wenner-Gren's institute at Stockholm University and a master's degree in Medicinal biotechnology from Umeå University. He also has industry experience as process engineer from Cobra Biologics.